'Jury's Still Out' On CRISPR Patent Licensing Pool

By Matthew Bultman (July 13, 2017, 9:56 PM EDT) -- The owners of key CRISPR patents have joined discussions to create a worldwide patent licensing pool, an important step in efforts to make the powerful gene-editing technology more widely available, although experts say "the jury's still out" about whether such a pool will be viable.

The Broad Institute of MIT and Harvard, along with joint owners Harvard University, the Massachusetts Institute of Technology and Rockefeller University, announced this week that it had submitted 22 CRISPR-Cas9 patents for consideration in a nonexclusive joint licensing pool.

There are concerns the current licensing landscape could impede development of human therapeutics because it can be...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!